Company news

Lunit Inc. (KRX:328130) news

Lunit Inc. news releases on 6ix. Latest, Sep 28, 2026: Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region

View Lunit Inc. →

Press releases & updates

Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region

September 28, 2026

Lunit Announces Collaboration with 10x Genomics to Integrate AI-Enabled Pathology Analysis with Spatial Molecular Data for Oncology Clinical Research

September 10, 2026

Lunit Unveils New AI-Powered Tumor Microenvironment Insights in Lung Cancer at WCLC 2026

September 8, 2026

Lunit Surpasses 330+ Sites and 1M Annual Screenings as Breast Imaging AI Moves into Clinical Practice

April 16, 2026

Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs

March 30, 2026

Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025

November 7, 2025

Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence

November 6, 2025

Lunit AI Predicts Immunotherapy Outcome in Colorectal, Kidney, and Lung Cancer at ESMO 2025

October 14, 2025

Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials

September 24, 2025

Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine

September 22, 2025

Lunit Showcases AI-Powered Cancer Ecosystem at APEC High-Level Meeting on Health and the Economy and World Bio Summit 2025

September 16, 2025

Lunit Awarded Major National Tender in France, Expanding Access to Breast AI in Public Hospitals

September 11, 2025

Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program

September 2, 2025

Lunit's AI Now Powers Cancer Screening for Over 14% of Italy's Population Through Public Health System

August 26, 2025

Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis

July 2, 2025

Lunit AI Used Again for Mass Screening During 2025 Hajj Season in Saudi Arabia

June 12, 2025

Lunit Launches Enhanced Lunit INSIGHT CXR4, Secures CE MDR Certification for Expanded AI Capabilities

May 28, 2025

Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies

May 26, 2025

Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition

May 19, 2025

Lunit to Power Germany's Largest Private Radiology Network with AI Imaging

May 7, 2025

Lunit Showcases AI Pathology Advances in Cancer Research from Rare to Common Tumors at AACR 2025

April 22, 2025

Lunit Study in Radiology Highlights Trust Gap Between Radiologists and AI in Breast Cancer Screening

April 9, 2025

Lunit Announces Partnership with the National Cancer Institute to Advance AI-Powered Biomarker Research

March 31, 2025

Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca

March 26, 2025

Lunit Secures Multi-Year Contract with UAE's Largest Healthcare Network to Power National AI Breast Cancer Screening Program

March 18, 2025

World's First Large-Scale, Multicenter Prospective Study in Single-Reading Mammography Confirms Lunit AI Boosts Cancer Detection

March 10, 2025

Lunit Expands Partnership with Saudi Arabia's Largest Medical Group to Deploy AI Chest X-Ray Solution

March 6, 2025

Lunit Achieves Milestone at ECR 2025: 13 Oral Presentations Among 15 AI Studies, Demonstrating Unmatched Clinical Impact

February 27, 2025

Lunit Announces Leadership Transition at Volpara: Craig Hadfield Appointed CEO

February 26, 2025